2-(3-Fluoro-4-methoxyphenyl)4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 10g

3-Bromo-2,4-dimethoxypyridine, 97%, 1g

2-(3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl)ethan-1-amine dihydrochloride, 95.0%, 2.5g

N-(4-(1-Aminoethyl)phenyl)cyclopropanecarboxamide, 98%, 10g

2-Hydroxymethyl-1-N-Boc-piperidine, 97.0%, 25g

4-((4'-methoxy-[1,1'-biphenyl])-4-sulfonamido)benzoic acid, 95.0%, 1g

Polvo de manganeso, bajo contenido de oxígeno 99,8+% 125-500 micrones 250 g

Methyl 5-bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylate, 95.0%, 10g

Methyl 2,4-dichloro-6-methylpyrimidine-5-carboxylate, 95.0%, 25g

3-Bromo-5-chlorotoluene, 98.0%, 10g

1-[6-(Aminomethyl)pyrimidin-4-yl]piperidin-2-one trihydrochloride, 1g

4-(4-Hydroxyphenyl)cyclohexanone, 95.0%, 500g

3-(3-(Cyclopentylthio)-5-(((2-methyl-4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)oxy)methyl)-4H-1,2,4-triazol-4-yl)pyridine, 98%, 10mg